Learn More
With the ongoing need to improve therapy for non-small cell lung cancer (NSCLC) there has been increasing interest in developing reliable preclinical models to test novel therapeutics. Patient-derived tumor xenografts (PDX) are considered to be interesting candidates. However, the establishment of such model systems requires highly specialized research(More)
s P1 P16 are educational and not included for publication online P2 Abstracts P1 P16 are educational and not included for publication online Breast Cancer Research 2012, 14(Suppl 1):P2 Abstracts P1 P16 are educational and not included for publication onlines P1 P16 are educational and not included for publication online P3 Abstracts P1 P16 are educational(More)
  • 1